Fennec Pharmaceuticals Inc. (FENC)
Automate Your Wheel Strategy on FENC
With Tiblio's Option Bot, you can configure your own wheel strategy including FENC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FENC
- Rev/Share 1.1209
- Book/Share 0.0903
- PB 87.0185
- Debt/Equity 0.0
- CurrentRatio 5.1338
- ROIC -0.3151
- MktCap 217082982.0
- FreeCF/Share -0.5816
- PFCF -13.5348
- PE -15.4039
- Debt/Assets 0.0
- DivYield 0
- ROE 5.8985
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript
Published: May 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Officer and Director Conference Call Participants Chase Knickerbocker - Craig Hallum Sudan Loganathan - Stevens Michael Okunewitch - Maxim Group Raghuram Selvaraju - H.C. Wainwright Operator Good morning, ladies and gentlemen.
Read More
Wall Street Analysts See an 113.25% Upside in Adherex Technologies (FENC): Can the Stock Really Move This High?
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
The average of price targets set by Wall Street analysts indicates a potential upside of 113.3% in Adherex Technologies (FENC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Read More
Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call Transcript
Published: March 10, 2025 by: Seeking Alpha
Sentiment: Neutral
Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q4 2024 Earnings Conference Call March 10, 2025 8:30 AM ET Company Participants Robert Andrade - CFO Jeff Hackman - CEO and Board Member Conference Call Participants Chase Knickerbocker - Craig-Hallum Raghuram Selvaraju - H.C. Wainwright Felix Ampomah - Stephens Michael Okunewitch - Maxim Group Operator Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Fourth Quarter and Full Year 2024 Earnings and Corporate Update Conference Call.
Read More
About Fennec Pharmaceuticals Inc. (FENC)
- IPO Date 2017-09-15
- Website https://www.fennecpharma.com
- Industry Biotechnology
- CEO Mr. Jeffrey S. Hackman
- Employees 32